openPR Logo

Press Releases from SMi Group (888 total)

Discuss, debate and learn from NATO partners & allies at SMi’s Mission Plannin …

SMi reports: Discuss, debate and learn from NATO partners & allies at SMi’s Air Mission Planning & Support conference 2018 As NATO partners & allies ended 2017 by taking steps to improve air power superiority, as illustrated by exercises Blue Flag, Optic Windmill and the Spartan Series, SMi invites attendees to discuss, debate and learn from these experts at Air Mission Planning & Support in London on 17th & 18th April

Exclusive new insight into Multi-Organ-Chip Technology

An Interview with Reyk Horland, Head of Business Development, TissUse GmbH, Ahead of 3D Cell Culture 2018 -------------------------------------------------------------------------------------- Since 2010 Reyk Horland is actively involved in the development of TissUse’s Multi-Organ-Chip platform for culture analysis of drug candidates, cosmetics, chemicals and consumer products. In his exclusive interview with SMi Group he talks about current industry trends and his upcoming presentation at the 3D Cell Culture Conference, 21-22 February, London Here is the extract

New Speakers Join this Year’s Line-Up at Border Security Conference

SMi Group Reports: New Speakers Join this Year’s Line-Up at Border Security Conference in February 2018. SMi have announced that Border Security returns to Rome on 21-22 February 2018 for its 11th annual conference. Ensure your opportunity to network with an audience of international senior security experts and law enforcement officers as they discuss the political and technological solutions being utilised to secure national borders. The event will welcome a number

Exclusive Speaker Interview from Janssen for SMi’s ADC Conference 2018

SMi are delighted to welcome Aman Singh, PK-PD Scientist, Janssen, onto the speaker panel for day 1 at ADC 2018! Aman received his Master’s in Pharmacometrics from Department of Pharmaceutical Sciences, UB from Dr. Wojciech Krzyzanski’s lab in 2012 working on translational PKPD models for monoclonal antibodies. He joined Dr. Dhaval Shah’s lab in 2013 for his PhD working on different aspects of Antibody-Drug Conjugates (ADCs). He is currently working the

An Overview of SMi’s 9th RNA Therapeutics this Feb 2018

Kickstart 2018 and attend the 9th annual RNA Therapeutics conference being held in London, this February 21st - 22nd. Benefit and learn from MHRA, MiNA Therapeutics, The RNA Institute, AstraZeneca, GSK, Sanofi and more! With an agenda full of exciting and new approaches, Day 1 will examine topics on using RNA for therapeutic opportunities including treating cystic fibrosis, liver cancer and skin diseases, and examine the novel approaches and emerging technologies

4 KEY QUESTIONS IN NEW EXPERIMENTAL TECHNOLOGIES ANSWERED AT SMI’s DRUG DISCOV …

SMi’s Drug Discovery conference taking place on 21st and 22nd March 2018, London will discuss the answers to 4 key questions in new experimental technologies within drug discovery. Hear William Janzen, Executive Director, Lead Discovery, Epizyme, review and compare biological and chemical validation of targets and answer whether CRISPR is enough. You can also hear Reyk Horland, Vice President, Business Development, TissUse GmbH provide multi-organ-on-a-chip solutions with case studies of

Join Pharmaceutical Social Media Experts in Just 2 Weeks! Only at #pharmasocialm …

Kickstart 2018 and attend the SMi’s 10th Annual Social Media in Pharma conference in just 2 weeks! Benefit from GSK, Pfizer, IBM, Janssen, Roche, CREATION, pharmaphorum, The Conversationalist Agency, Bristol-Myers Squibb, MSD, ABPI, and more! With an agenda full of exciting and new approaches for communicating with patients online, dive deep into topics surrounding social listening, interactions and engagement, writing effective content and tracking ROI from social media, and why social

Hear from a Top 100 Global Social Media Influencer of 2017, only @SMi’s 10th A …

SMi are delighted to welcome Dr. Paul Tunnah, CEO, pharmaphorum, onto the agenda! - Listed in the top 100 global business influencers for 2017 - Dr Paul Tunnah founded pharmaphorum in 2009, and it has rapidly evolved and developed its services to drive better communication, connection and collaboration between the pharmaceutical industry and other healthcare stakeholders through both its digital publication and specialist content consultancy (pharmaphorumconnect). Paul is a recognised author, speaker

Hear from Janssen and Antikor Biopharma at SMi’s ADC Conference, May 2018

SMi's ADC conference will be bringing a global presence from Pfizer, Genentech, Ablynx, Spirogen, Seattle Genetics, Medimmune, Antikor Biopharma, Heidelberg Pharma and more. With an agenda full of exciting and new approaches, examine the latest developments in antibodies and antibody drug conjugates, including drug design, PK-PD and technological advancements, warheads and site selectivity, highly potent ingredients and immune-oncological combination therapies. SMi Group are delighted to welcome your input and have you

MHRA Update: Regulatory Considerations for The Registration of New Antibacterial …

Taking place in London on 19th and 20th March 2018, the theme for SMi’s 20th annual conference on Superbugs and Superdrugs is to tackle the scientific, regulatory and economic challenges to combat AMR. Highlights will include an exclusive keynote address from the MHRA when SMi Group welcomes the expertise of Mair Powell to provide regulatory guidance on the registration of new antibacterial agents. Dr. Powell is a member of the EMA’s Infectious

The Cold Chain Industry Will Gather in Less Than 24 Hours for Cold Chain Distrib …

Europe’s leading gathering of Life Sciences, Logistics, Supply Chain & Cold Chain Professionals will yet again reunite tomorrow to start the important dialogue concerning GDP requirements across Europe. Produced with a theme of “creating conversation” the two-day programme focuses on delivering industry leverage that you can implement in your day-to-day business operations. This year's event will feature the following new highlights: • Hear exclusive first-hand industry updates on how new trends are

SMi’s Defence Logistics (CEE): World Fuel Services, HIAB, TVS (SCS) Join Them …

Defence Logistics Central & Eastern Europe will present over 18 peer-led sessions, including case studies and panel discussions, 5+ hours of networking, 12 hours of highly interactive content, all under one roof this coming March. Aside from the global military speaker line-up, benefit from briefings by highly experienced solution providers within the defence industry who specialise in a range of military equipment and supplies. World Fuel Services: At the forefront of the global

STORM Therapeutics Joins SMi’s 9th Annual RNA Therapeutics

SMi are delighted to welcome Oliver Rausch, VP Research & Development, Storm Therapeutics, onto the speaker line-up for day 1 at RNA Therapeutics 2018! Oliver has overall responsibility for developing STORM’s target discovery platform and for the delivery of small molecule drugs from its emerging drug discovery pipeline. Oliver worked closely with scientific founders Professors Tony Kouzarides and Eric Miska to secure the initial £12m series; an investment that launched STORM

How do doctors’ conversations differ from private to public social networks?

SMi are delighted to welcome Jamie Doggett, Senior Research Analyst, CREATION and Akash Degan, Vice President of Business Development, SERMO onto the speaker panel! About Jamie Doggett: Jamie Doggett is a Senior Research Analyst at CREATION, a global strategy consultancy. Jamie manages the development of intelligence insights using CREATION Pinpoint, a platform which is a worldwide lead in learning from healthcare professionals on public social media. He uses data analytics to find

OFWAT to Open SMi’s 7th Annual Conference on Smart Water Systems

SMi Group are delighted to have David Black from OFWAT open the 7th Annual conference on Smart Water Systems when it returns to Central London next April. David is a Senior Director at OFWAT, the economic regulator of the water sector in England and Wales. He currently leads both the Water 2020 programme covering wholesale markets; and the 2019 price review (PR19). With a focus on regulation for innovation and

Operational Case Studies and Guidance in Overcoming Challenges of Delivering Hig …

With great strides being made in formulation and manufacturing processes, concerns over changing regulations and excitement over evolving PFS technologies, SMi’s 5th annual Pre-Filled Syringes East Coast conference and exhibition will return to Boston next April offering a compelling outlook into the latest industry developments. The event will feature an array of operational case studies and keynote addresses from medical device experts and market specialists, allowing attendees to expand their horizons

“SPARKing" New Antibiotic Drug Discovery

Kathy Talkington, Project Director from Pew Charitable Trusts, will discuss the "Shared Platform for Antibiotic Research and Knowledge" when she presents a keynote on "SPARKing" new antibiotic drug discovery at SMi’s 20th annual conference on Superbugs and Superdrugs next March in Central London. With a background in managing and developing immunization and infectious disease programs and policies, Kathy Talkington is currently responsible for Pew’s work on antibiotics. Pew seeks to address

Complex Co-Cultured Spheroids to Validate Tumour Models in Microfluidic Devices

Following on from recent reports that suggests spheroids could serve as a testing ground to help scientists zone in on personalised treatments for cancer, SMi Group are delighted to have Post-Doctoral Researcher, Tudor Petreus from AstraZeneca, presents on "Complex co-cultured spheroids to validate tumour models in microfluidic devices" at the next annual conference on 3D Cell Culture next February. Tudor Petreus is currently responsible for development of complex 3D

Quality Assurance and Manufacturing Processes: New Updates Presented at Pre-Fill …

The Pre-Filled Syringes Europe conference and exhibition is almost here and will return to Central London next month on 17th and 18th January. With more speakers, more sessions, and more solutions in the agenda for the 10th annual show, SMi Group promises to equip attendees with more knowledge and more key contacts to help them propel their injectable device into 2018. Highlights will include a spotlight on manufacturing processes featuring two

Discover how to grab the attention of your social audience

Social Media in the Pharmaceutical Industry conference will be bringing a global presence from GSK, Pfizer, IBM, Janssen, Roche Diabetes Care, Bristol-Myers Squibb, MSD, ABPI, and more. With an agenda full of exciting and new approaches for communicating with patients online, dive deep into topics surrounding social listening, interactions and engagement, writing effective content and tracking ROI from social media. Discover how to grab the attention of a social audience with

Andrew Hopkins, Chief Executive at Exscientia to discuss the role of Artificial …

SMi reports: Andrew Hopkins, Chief Executive at Exscientia to discuss the role of Artificial Intelligence in small molecule drug discovery at SMi’s Drug Discovery conference in March 2018 The world’s leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines, with GlaxoSmithKline unveiling a new $43 million deal in the field on Sunday.“Many large pharma companies are starting to realize the potential of this

Highly Anticipated Attendee List Released for Cold Chain Distribution 2017

Preliminary attendee list released featuring Cool Chain Association, GlaxoSmithKline, MedImmune, Merck SpA, Mylan, Pfizer, Sanofi and Saudi FDA. (LONDON, UK) SMi’s Cold Chain Distribution Conference & Exhibition will take place on 13-14 December 2017 at the Copthorne Tara Hotel in London, UK. Growing year on year, SMi’s 12th annual Cold Chain Distribution conference and exhibition has attracted an audience of over 120 senior logistic pioneers and cold chain experts, with experience

Highly Anticipated Agenda Out for Smart Water Systems 2018 Featuring Ofwat, Tham …

SMi is delighted to announce the return of the 7th Annual Smart Water Systems Conference, which will be held in London on the 25th and 26th April 2018. As well as discussing market drivers responsible for rapid market growth, Smart Water Systems 2018 will address the increasingly large role that data and information plays in the water management industry and analyse various data strategies and the demand for operational implications for

The Overlap of 3D Bioprinting and 3D Cell Culturing in Cancer Research

SMi’s 3D Cell Culture conference will gather together a room full of CEOs, scientific pioneers and senior decision makers directly under one roof. Taking place in London on 21st and 22nd February 2018, the theme for the 2nd annual show is to strengthen commercial success through combining clinical breakthroughs with scientific research. Highlights will include a look into the overlap of 3D bioprinting and 3D cell culturing in cancer research

Pfizer presents the opening keynote at the SMi’s ADC Conference 2018

SMi’s global panel of speakers will strengthen your knowledge in key topics such as high potent ingredients, ADC payloads, PK-PD technological advancements, warheads and site selectivity, immune-oncological combination therapies and fragment drug conjugates. Industry News: Pfizer received FDA approval for Mylotarg™ (Gemtuzumab Ozogamicin), in 2000 the only approved antibody-drug conjugate for newly diagnosed and relapsed or refractory CD33-positive acute myeloid leukemia. It has been recently announced that earlier this year, Pfizer resubmitted

SMi’s Defence Logistics: Hear from the Austrian Logistics Command, Defence Log …

Hear from the Austrian & German Logistics Commands as well as the US Defence Logistics Agency, German Armed Forces and the NCIAgency this March Day 1 | 11:00 | Increasing Transportation Logistics Development to Guarantee Faultless Delivery Brigadier General Thomas Hambach, Deputy Commander, Logistics Command, German Armed Forces Brigadier General Hambach brings with him extensive knowledge and experience, and will deliver a briefing concerning the increase to transportation logistics development so as to

Reyk Horland, Vice President, Business Development at TissUse GmbH to discuss mu …

SMi reports: Reyk Horland, Vice President, Business Development at TissUse GmbH to discuss “Applying Multi-Organ-on-a-Chip Technologies for Predictive Substance Testing" at SMi’s Drug Discovery conference in March 2018 Multi-organ-on-a-chip is a device which replicates the organs in a human body. This device can hugely increase the drug discovery and development process. The global multi-organ-on-a-Chip market is expected to reach $170 million by 2023* with a compound annual growth rate of 63.2

Superbugs: Exclusive Interviews Released with ABAC Therapeutics, Alchemy Biomedi …

SMI REPORTS: Expert insight into tackling the scientific, regulatory and economic challenges to combat antimicrobial resistance. It is imperative for medical experts and drug discovery specialists to stay on top of the latest clinical advancements, developments and industry initiatives related to antimicrobial resistance. For this reason, SMi Group have gathered industry experts and government bodies to share their insights at the 20th annual conference on Superbugs and Superdrugs taking place on

Highly Anticipated Agenda Released for Pre-Filled Syringes East Coast 2018

SMi Group Reports: Pre-Filled Syringes East Coast Returns to Boston, USA with Panel Featuring Shire, Eli Lilly, Takeda, Sanofi, Teva Pharmaceuticals, MedImmune and GSK Building on the success of previous sell-out shows, SMi Group is delighted to announce the return of the 5th annual conference and exhibition: Pre-Filled Syringes - East Coast, taking place on April 11th – 12th 2018 in Boston, Massachusetts, USA. A rise in chronic diseases, improvements in technology

An Interview with Bjorg K. Hunter, Device Engineering Manager from GSK Ahead of …

SMi Group will welcome the expertise of Bjorg K. Hunter, Device Engineering Manager from GSK, when she participates on a panel debate at Pre-Filled Syringes Europe 2018 alongside West Pharmaceutical Services, Novartis Pharma AG and Merck. The conference and exhibition will return to Central London for its 10th annual installment next January and has already attracted a global audience of attendees from Austria, Belgium, Denmark, France, Germany, Italy, Japan, Netherlands, Switzerland,

Topics Presented this February 2018 at RNA Therapeutics

Learn more about: - How The RNA Institute is using a unique RNA target to engineer a novel antibiotic. - The opportunities that small activating RNA can bring in drug development. - How to utilise RNA epigenetics, by targeting RNA modifying enzymes. - Drafting a successful new patent application for an RNA therapeutic. - The advances in targeted delivery of nucleotides beyond the liver. - Targeting liver hepatocytes using alternative delivery approaches with siRNA. - The important

Discover the future of 'social pharma', only at Social Media in the Pharmaceutic …

Returning to London this January 2018, Day 1 will address topics on wearable technologies, patient engagement and social media strategies; while Day 2 covers interaction using social media, digital health strategies and effective content. 3 Key Social Media Priorities for the Pharmaceutical Industry 1. The Digital Customer Journey Optimising the customer journey across multiple touchpoints will be very important for companies' marketing for the coming future. Healthcare and pharma companies are 14% more

Improving Access to Innovative Paediatric Medicines

Paediatric Clinical Trials 2018 recognises the continuing need for education amongst Clinical Research Professionals responsible for the activities at the research site or institution. Next year's event will focus on assisting Research Professionals in improving their skills and their understanding of the responsibilities of conducting clinical research in the paediatric population. Through a series of presentations, practical applications and a supporting workshop facilitated by clinical research professionals, information will be presented

SMi’s Europe’s Leading Ophthalmic Conference is only 2 weeks away!

QUICK UPDATE: SMi’s Ophthalmic Drugs will be taking place in JUST 2 WEEKS at the Copthorne Tara Hotel in London, Kensington UK. Network with top pharma companies are joining us including Boehringer Ingelheim, Bayer, Envisia Therapeutics, NightstaRx, Shire, Novaliq GmbH and more. www.ophthalmicdrugs.com/opr [NEW ATTENDEES] - Fresenius Kabi | Nanoptima | Nicox [NEW SPEAKER] - We are delighted to welcome Sunil Shah, Professor/Director, Midland Eye Centre onto the programme! With a global presence,

Pre-Filled Syringes: An Increased Focus on Safety and Human Centred Approaches

SMi Group will focus on patient needs in parenteral drug delivery in an exclusive spotlight at the 10th annual Pre-Filled Syringes Europe conference and exhibition when it returns to Central London next January. It is imperative for parenteral drug delivery professionals and medical device experts to stay on top of the latest advancements, technologies and processes related to the evolving landscape of Pre-Filled Syringes. However, the requirements placed on the syringe

Updated agenda released for Network Centric Warfare 2018

SMi Group’s Network Centric Warfare conference returns to Rome on 1-2 February in Rome, Italy. Now featuring 19 exclusive presentations, a pre-conference workshop, and dedicated networking sessions, SMi’s Network Centric Warfare 2018 aims to provide delegates an intelligent forum to explore strategic integration of networked systems and military forces to achieve operational superiority. Day 1 will provide updates on digital fire support, communication interoperability and digitalisation of the battlespace. Day 2

Agenda released for SMi’s 20th Annual Superbugs European Show Featuring Keynot …

SMi Group have released an agenda for the 20th annual Superbugs & Superdrugs conference returning to Central London on 19th and 20th March 2018. Welcoming expertise from some of the most senior industry thought leaders in infectious disease and medical research such as the MHRA, GARDP (DNDi), Nemesis Bioscience, Gladius Pharmaceuticals and Chemical Biology, SMi's flagship conference in the global Superbugs & Superdrugs series will once again provide a platform to

Industry Gathers Next Week at Pharmaceutical Microbiology East Coast

Building on SMi's continuous success and year on year growth in both Europe and across the USA, the Pharmaceutical Microbiology series is firmly becoming established as the industry's premier platforms for updates on rapid microbial methods, sterility testing and contamination control. Don't miss the chance to book your place before registration closes. The conference will host over 14 presentations from a mix of leading industry players and big pharma such as

3D Cell Culture 2018: Exclusive New Interviews Released with Aurelia Bioscience, …

SMI REPORTS: SMI REPORTS: Expert insight into 3D Cell Culture advancements and challenges in commercialisation It is imperative for scientific researchers and drug discovery specialists to stay on top of the latest advancements, technologies and processes related to 3D Cell Culture. For this reason, SMi Group have gathered industry experts to share their insights at 3D Cell Culture 2018 taking place on 21st and 22nd February in London, UK SMi Group had

SMi Group: Exclusive Speaker Interview with Professor Nagy Habib - MiNA Therapeu …

SMi are delighted to have, Nagy Habib, Head of HPB Surgery, Imperial College London and Co-Founder, MiNA Therapeutics, as the Keynote Address for day 1 at RNA Therapeutics 2018! Professor Nagy Habib is Head of HPB Surgery at the Hammersmith Campus of Imperial College London and Co-Founder, MiNA Therapeutics. He is also a serial founder and entrepreneur of life sciences ventures. He is co-founder of several biotech companies: EMcision Ltd, OmniCyte

Intellectual Property and Regulatory Law: Recent Developments | Parallel Trade 2 …

Generic drug manufacturers can pose major financial threats to the companies that invent and develop the copied drugs both domestically and internationally. Even after a pharmaceutical company is granted patent protection on its products, there are other concerns about generics that Big Pharma face from abroad. SMi’s 12th annual Parallel Trade conference, will return to Central London, 6th – 7th February 2018 to explore the relationship between parallel trader and the

Final Reminder: 1 Week Until SMi’s Lyophilization USA

With the event now just 1 week away, a gentle reminder that there is still time to secure your place at SMi's 3rd annual event, Lyophilization USA, taking place on November 16th and 17th in Iselin, New Jersey. Looking to create a competitive edge, reduce manufacturing costs and shorten cycle time through understanding key parameters in pharmaceutical freeze-drying? Receive guidance on QbD submissions? Gain an overview of the latest innovations

Transforming complex biologics delivery and enhancing patient experience

Amgen unveil novel drug delivery technologies next January at Pre-Filled Syringes Europe 2018. SMI Reports: SMi Group will welcome the expertise of Sudeshna Dutta Ray when she presents at the 10th annual Pre-Filled Syringes Europe conference on 17th and 18th January in Central London. Sudeshna Dutta Ray is a Senior Engineer in the Advanced Device Technology and Innovation (ADTI) group in Amgen which serves as the front end of device innovation within

Merging CRISPR- editing and single cell sequencing technologies to uncover the b …

Case studies with Zika virus and tuberous sclerosis presented at next annual industry summit on 3D Cell Culture SMi Group will welcome the expertise of Max Salick when he presents case study insight at the second annual conference on 3D Cell Culture which returns to Central London on 21st and 22nd February in 2018. Max Salick is a postdoctoral scholar in the Neuroscience Department of the Novartis Institutes for Biomedical Research in

Agenda released for SMi Group’s Controlled Release Delivery 2018

Building on the success of previous events, SMi has announced the return of its 15th annual Controlled Release Delivery, taking place on 21st and 22nd March in London, UK. An industry-leading show, the conference has been running for 15 years - a testament of how vital this particular focus is to the biotech and pharma sector. As physicians and scientists continue to find strategies to assist in simplifying treatment schedules for

The Power of Partnerships: Meeting Pharmaceutical Logistic Excellence

This year's Cold Chain Distribution conference programme is insightful and features many of the major players from cold chain and logistics sectors. Some of these exciting speakers have been announced in the past weeks, but recently we added some new notable names to our keynote lineup. They represent various logistic companies and, adjacent sectors, see a few of the proficient speakers below. Over 18 speakers have been announced, the complete

Pre-Filled Syringes Europe 2018 Attendee List Released

SMi Group release preliminary attendee list featuring MHRA, Boehringer Ingelheim, Janssen, Amgen, Merck and Novartis, 3P Innovation, Intertek, Nemera, Terumo, Worrell and Zeon Now firmly established as one of the industry’s leading platforms for new updates on pre-filled syringes, SMi’s 2017 global PFS portfolio attracted an audience of over 300 senior drug delivery and medical device experts. Growing year on year, the flagship 10th annual 2018 Pre-Filled Syringes Europe conference already

Leveraging 4 Key Drivers in a $6.36 Billion PFS Market at 10th Annual Pre-Filled …

A recent report has predicted the Global Prefilled Syringes Market to exceed more than US$ 6.36 Billion by 2022 at a CAGR of 10.1%.* In light of this, SMi Group will return to Central London next January with its 10th annual event, Pre-Filled Syringes Europe 2018, to leverage key drivers effecting a rapidly booming market * Source: http://bit.ly/2gpR3Pd 1. Simplicity and ease of use: Pre-Filled Syringes reduce the number of steps

New Confirmed Delegates & Speakers for RNA Therapeutics

SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led

Spotlight on Key Sessions at Ophthalmic Drugs this November

Featuring an exceptional line-up of keynote speakers from industry leading organisations, Europe's leading conference on Ophthalmic Drugs arrives at the perfect time to discuss the latest approaches in key areas such as ocular diseases, drug delivery, pre-clinical and clinical trials, computer technologies and therapies for diabetic macular oedema. www.ophthalmicdrugs.com/opr Agenda highlights will include a spotlight on dry eyes, therapies for glaucoma and emerging computer technologies to drug development in ophthalmology. Spotlight Summary

Go To Page:    11 12 13 14 15 16 17 18 19 20